Exubera vs Lispro in a Lantus-based Regimen for Improved Glycemic Control in Type 2 Diabetes

NCT00348374 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus

Interventions

DRUG: Insulin Lispro
DRUG: Exubera

Sponsor

Pfizer